What is Barclays's price target for CAH?

Barclays's latest stated price target for Cardinal Health Inc. (CAH) is $243, from its action on Dec 9, 2025.

What is Barclays's rating on CAH?

Barclays rates CAH Overweight, a bullish rating, as of Dec 9, 2025.

When did Barclays last change its view on CAH?

On Dec 9, 2025, Barclays starts coverage at Overweight, price target $243.

Barclays CAH price target and rating history

Cardinal Health Inc. (CAH) · Health Care

Barclays rates Cardinal Health Inc. (CAH) Overweight with a $243 price target, as of its latest action on Dec 9, 2025. It has published 6 rating actions on CAH since August 2021, including 0 upgrades and 1 downgrade.

Current rating: Overweight
Price target: $243
Median target, all firms: Too few
Actions on CAH: 6

Barclays price target on CAH

Barclays price target on CAH, each point a stated target, August 2021 to December 2025.

Every Barclays rating on CAH

Dec 9, 2025
InitiateBarclays starts coverage at Overweight, price target $243
Jan 3, 2024
InitiateBarclays starts coverage at Overweight, price target $117
May 26, 2022
DowngradeBarclays downgrades to Equal Weight from Overweight
Jan 11, 2022
ReiterateBarclays cuts its price target to $63 from $65, keeps Overweight
Nov 10, 2021
ReiterateBarclays cuts its price target to $65 from $68, keeps Overweight
Aug 6, 2021
ReiterateBarclays cuts its price target to $68 from $71, keeps Overweight

How other firms rate CAH

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
RBC Capital Markets	Outperform	$276	Aug 19, 2026
William Blair	Outperform		Apr 28, 2026
Citigroup	Buy		Jan 9, 2026
Barclays	Overweight	$243	Dec 9, 2025

Questions about Barclays and CAH

What is Barclays's price target for CAH?: Barclays's latest stated price target for Cardinal Health Inc. (CAH) is $243, from its action on Dec 9, 2025.
What is Barclays's rating on CAH?: Barclays rates CAH Overweight, a bullish rating, as of Dec 9, 2025.
When did Barclays last change its view on CAH?: On Dec 9, 2025, Barclays starts coverage at Overweight, price target $243.

More CAH rating histories

All Barclays ratings CAH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.